|
1.
|
Schmitt C, Miranpuri GS, Dhodda VK,
Isaacson J, Vemuganti R and Resnick DK: Changes in spinal cord
injury-induced gene expression in rat are strain-dependent. Spine
J. 6:113–119. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Hong Z, Chen H, Hong H, Lin L and Wang Z:
TSP-1 expression changes in diabetic rats with spinal cord injury.
Neurol Res. 31:878–882. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Grasso G, Sfacteria A, Meli F, Fodale V,
Buemi M and Iacopino DG: Neuroprotection by erythropoietin
administration after experimental traumatic brain injury. Brain
Res. 1182:99–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hasselblatt M, Ehrenreich H and Siren AL:
The brain erythropoietin system and its potential for therapeutic
exploitation in brain disease. J Neurosurg Anesthesiol. 18:132–138.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ishii Y, Oya T, Zheng L, et al: Mouse
brains deficient in neuronal PDGF receptor-beta develop normally
but are vulnerable to injury. J Neurochem. 98:588–600. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bergsten E, Uutela M, Li X, et al: PDGF-D
is a specific, protease-activated ligand for the PDGF
beta-receptor. Nat Cell Biol. 3:512–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Wu QH, Chen WS, Chen QX, Wang JH and Zhang
XM: Changes in the expression of platelet-derived growth factor in
astrocytes in diabetic rats with spinal cord injury. Chin Med J
(Engl). 123:1577–1581. 2010.PubMed/NCBI
|
|
8.
|
Janmaat ML, Heerkens JL, de Bruin AM,
Klous A, de Waard V and de Vries CJ: Erythropoietin accelerates
smooth muscle cell-rich vascular lesion formation in mice through
endothelial cell activation involving enhanced PDGF-BB release.
Blood. 115:1453–1460. 2010. View Article : Google Scholar
|
|
9.
|
Montero M, Poulsen FR, Noraberg J, et al:
Comparison of neuroprotective effects of erythropoietin (EPO) and
carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose
deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal
slice cultures. Exp Neurol. 204:106–117. 2007. View Article : Google Scholar
|
|
10.
|
Okutan O, Solaroglu I, Beskonakli E and
Taskin Y: Recombinant human erythropoietin decreases
myeloperoxidase and caspase-3 activity and improves early
functional results after spinal cord injury in rats. J Clin
Neurosci. 14:364–368. 2007. View Article : Google Scholar
|
|
11.
|
Grasso G, Sfacteria A, Passalacqua M, et
al: Erythropoietin and erythropoietin receptor expression after
experimental spinal cord injury encourages therapy by exogenous
erythropoietin. Neurosurgery. 56:821–827. 2005. View Article : Google Scholar
|
|
12.
|
Adamcio B, Sargin D, Stradomska A, et al:
Erythropoietin enhances hippocampal long-term potentiation and
memory. BMC Biol. 6:372008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
King VR, Averill SA, Hewazy D, Priestley
JV, Torup L and Michael-Titus AT: Erythropoietin and carbamylated
erythropoietin are neuroprotective following spinal cord
hemisection in the rat. Eur J Neurosci. 26:90–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Bittorf T, Buchse T, Sasse T, Jaster R and
Brock J: Activation of the transcription factor NF-kappaB by the
erythropoietin receptor: structural requirements and biological
significance. Cell Signal. 13:673–681. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhang W, Sun B, Wang X, Liu J, Zhang Z and
Geng S: Erythropoietin enhances survival of facial motor neurons by
inhibiting expression of inducible nitric oxide synthase after
axotomy. J Clin Neurosci. 17:368–371. 2010. View Article : Google Scholar
|
|
16.
|
Enge M, Wilhelmsson U, Abramsson A, et al:
Neuron-specific ablation of PDGF-B is compatible with normal
central nervous system development and astroglial response to
injury. Neurochem Res. 28:271–279. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yang C, Li B, Liu TS, Zhao DM and Hu FA:
Effect of electracupuncture on proliferation of astrocytes after
spinal cord injury. Zhongguo Zhen Jiu. 25:569–572. 2005.(In
Chinese).
|
|
18.
|
Huang X, Kim JM, Kong TH, et al: GM-CSF
inhibits glial scar formation and shows long-term protective effect
after spinal cord injury. J Neurol Sci. 277:87–97. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Egawa-Tsuzuki T, Ohno M, Tanaka N, et al:
The PDGF B-chain is involved in the ontogenic susceptibility of the
developing rat brain to NMDA toxicity. Exp Neurol. 186:89–98. 2004.
View Article : Google Scholar : PubMed/NCBI
|
